Chatur, S., Claggett, B. L., Miao, Z. M., Hernandez, A. F., Morrow, D. A., Starling, R. C., … Vaduganathan, M. (2024). Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF. In EUROPEAN JOURNAL OF HEART FAILURE (Vol. 26, pp. 254–254).

Chatur, Safia, B. L. Claggett, Z. M. Miao, A. F. Hernandez, D. A. Morrow, R. C. Starling, E. J. Velazquez, et al. “Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF.” In EUROPEAN JOURNAL OF HEART FAILURE, 26:254–254, 2024.

Chatur S, Claggett BL, Miao ZM, Hernandez AF, Morrow DA, Starling RC, et al. Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF. In: EUROPEAN JOURNAL OF HEART FAILURE. 2024. p. 254–254.

Chatur, Safia, et al. “Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF.” EUROPEAN JOURNAL OF HEART FAILURE, vol. 26, 2024, pp. 254–254.

Chatur S, Claggett BL, Miao ZM, Hernandez AF, Morrow DA, Starling RC, Velazquez EJ, Desai AS, Ward JH, Williamson KW, Mentz RJ, Zieroth S, Solomon SD, Vaduganathan M. Safety and efficacy of sacubitril/valsartan in patients with heart failure with mildly reduced or preserved EF after a worsening heart failure event based on diuretic use in PARAGLIDE-HF. EUROPEAN JOURNAL OF HEART FAILURE. 2024. p. 254–254.